Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra
Go back to Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra| (NASDAQ: MDGL) | Delayed: 508.33 +2.58 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $505.75 | 52 Week High | $18.24 | |||
| Open | $513.23 | 52 Week Low | $6.60 | |||
| Day High | $515.00 | P/E | N/A | |||
| Day Low | $505.91 | EPS | $0.00 | |||
| Volume | 29,531 | |||||

